ERBB2 and neoplasm: Although HER2 overexpression by IHC is defined by ASCO/CAP as >10% complete, circumferential, and strong IHC 3+ staining, there are currently no published studies correlating the significance of the relative amount of 3+ staining in a tumor with response to NAC.